FDA approves J&J's pancreatic enzyme product
This article was originally published in Scrip
Executive Summary
The US FDA has approved Johnson & Johnson's pancreatic enzyme product (PEP), Pancreaze delayed-release capsules, to improve food digestion in patients who do not produce enough pancreatic enzymes, making it the third such product to receive approval.